Clinical Study Of Invigorating Lung And Strengthening Spleen Therapy Combined With Biqiu Lavipeditum Prescription In Treatment Of Allergic Rhinitis Of Lung And Spleen Qi Deficiency

ObjectiveThis study was conducted to observe the effect of invigorating lung and strengthening spleen therapy combined with Biqiu lavipeditum prescription on the symptoms and sign of patients with allergic rhinitis of lung and spleen qi deficiency and its clinical efficacy,in order to find effective and reliable traditional Chinese medicine treatment of allergic rhinitis,and in order to provide clinical basis for the further study of traditional Chinese medicine treatment of allergic rhinitis.MethodsFrom April to September 2018,90 patients visiting the department of Otolaryngology,Shenzhen Traditional Chinese Medicine Hospital,who met the diagnostic criteria of allergic rhinitis and met the criteria of traditional Chinese medicine syndrome differentiation of lung spleen qi deficiency,were randomly divided into group A,group B and group C,each group of 30 cases.The group A was treated with invigorating lung and strengthening spleen therapy combined with Biqiu lavipeditum prescription.The group B was treated invigorating lung and strengthening spleen therapy combined with warm water lavipeditum.The group C was only treated with invigorating lung and strengthening spleen therapy.The course of treatment was 8 weeks.Before treatment,after 4 weeks of treatment and after 8 weeks of treatment,the patients were scored for their sneezing,runny nose,nasal congestion,nasal itching symptoms and related nasal sign according to the scoring criteria,and the clinical efficacy was calculated according to the changes of the scores.Statistical analysis was performed by using SPSS 19.0 to compare the effects of the three treatments on the symptoms and sign of the patients and their clinical efficacy.Results1 There were no significant differences in age,duration of disease and sex ratio between the three groups(P>0.05),which were comparable.2.There were no significant differences in each symptom and sign score and total score between the three groups before treatment(P>0.05).3 A’fter 4 weeks of treatment,each symptom and sign score and total score of the three groups were significantly different(P<0.05).The sneezing,runny nose,nasal itching score and total score of group A were significantly lower than those of group B(P<0.05).There was no significant difference in nasal congestion and sign score between group A and group B(P>0.05).Each symptom and sign score and total score of group A were significantly lower than those of group C(P<0.05).The nasal congestion and sign of group B were significantly lower than group C(P<0.05),and there was no significant difference in sneezing,runny nose,nasal itching score and total score between group B and group C(P>0.05).4 After 8 weeks of treatment,each symptom and sign score and total score of the three groups were significantly different(P<0.05).Each symptoms and sign score and total score of group A were significantly lower than those of group B and group C(P<0.05).The nasal congestion and sign score of group B were significantly lower than those of group C(P<0.05).There was no significant difference in the sneezing,runny nose,nasal itching score and total score between group B and group C(P>0.05).5 After 4 weeks and 8 weeks of treatment,each symptom and sign score and total score of the three groups were significantly lower than those before treatment(P<0.05).After 8 weeks of treatment,each symptoms score and total score were significantly lower than those after 4 weeks of treatment(P<0.05).The sign score of group A and group B after 8 weeks of treatment were significantly lower than that after 4 weeks of treatment(P<0.05).There was no significant difference between the sign score after 4 weeks and 8 weeks of treatment(P>0.05).6 After 4 weeks of treatment and 8 weeks after treatment,there were significant differences in the efficacy of the three groups(P<0.05).The efficacy of group A was significantly better than that of group B and group C(P<0.05).There was no significant difference between group B and group C(P>0.05)·7.After 8 weeks of treatment,the efficacy of the three groups was significantly better than that of the same group after 4 weeks(P<0.05).Conc!usion1.The invigorating lung and strengthening spleen therapy combined with Biqiu lavipeditum prescription can significantly improve the sneezing,runny nose,nasal congestion and nasal itching symptoms and related sign in patients with allergic rhinitis of lung and spleen qi deficiency.The clinical efficacy is definite.This method is significantly better than invigorating lung and strengthening spleen therapy combined with warm water lavipeditum and simply invigorating lung and strengthening spleen therapy on the improvement of each symptom and sign and clinical efficacy.2.The invigorating lung and strengthening spleen therapy combined with Biqiu lavipeditum prescription is a safe and reliable therapy,and no treatment-related adverse reactions occur in the treatment of patients with allergic rhinitis.